Kwang-Ho In

Title: Kwang-Ho In: Innovator in Asthma Research

Introduction

Kwang-Ho In is a notable inventor based in Brookline, MA (US). He has made significant contributions to the field of asthma research, particularly through his work on the 5-lipoxygenase gene. With a total of 2 patents, his innovations have the potential to improve patient classification and treatment responsiveness.

Latest Patents

Kwang-Ho In's latest patents focus on the identification of sequence polymorphisms in the 5-lipoxygenase gene. The first patent, titled "5-Lipoxygenase gene polymorphisms and their use in classifying patients," provides methods for correlating these polymorphisms with asthmatic phenotype and responsiveness to therapy. It highlights that individuals with reduced 5-lipoxygenase expression are less responsive to treatment with 5-lipoxygenase inhibitors. The second patent, "Identification of asthma patients who are candidates for effective treatment," shares similar findings and emphasizes the importance of genetic factors in asthma management.

Career Highlights

Kwang-Ho In is affiliated with The Brigham and Women's Hospital, Inc., where he conducts his research. His work has been instrumental in advancing the understanding of asthma and its genetic underpinnings.

Collaborations

He has collaborated with esteemed colleagues such as Jeffrey M Drazen and Koichiro Asano, contributing to a rich environment of innovation and research.

Conclusion

Kwang-Ho In's contributions to asthma research through his patents and collaborations highlight the importance of genetic research in improving patient care. His work continues to pave the way for advancements in the classification and treatment of asthma.